Additionally, Risinger’s confidence is bolstered by the planned Phase 3 trials for VX-548 as a treatment for diabetic peripheral neuropathy (DPN), slated to begin in the second half of 2024.
It's certainly positive to see the recent insider purchase. We also take confidence from the longer term picture of insider transactions. However, we note that the company didn't make a profit ...
Members of the Indiana University Bloomington faculty overwhelmingly voted “no-confidence” in President Pamela Whitten, Provost Rahul Shrivastav and Carrie Docherty, vice provost for faculty ...
White collar recruitment giant Hays says that ... said that the uncertain economic environment had hit the confidence of both candidates and employers. As a result, companies were taking longer ...
President Pamela Whitten, IU’s 19th president and first woman to serve in the role, will be subject to a vote of no confidence Tuesday — not even three years after she first stepped foot on campus in ...
State Dept stands by DEI chief who bemoaned White feminism, called America a 'failed historic model'
The State Department responded to the controversy surrounding its new diversity, equity and inclusion chief Zakiya Carr Johnson, explaining that it has "high confidence" in her ability to lead in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results